A REVIEW ON CHITHIRAMOOLA KULIGAI – THERAPEUTIC APPROACH FOR CERVICAL CANCER IN ACCORDANCE WITH SIDDHA PRINCIPLES

Main Article Content

Subathra T
Gomathi R
Shanmugapriya P
Ramamurthy M
Meenakumari R

Keywords

Cervical cancer, Integrative care, Siddha, Chithiramoola kuligai, Patient-centered care

Abstract

Cervical cancer remains a significant global health challenge, claiming millions of lives annually despite advancements in medical science. This paper explores the multifaceted landscape of cervical cancer treatment, examining both conventional approaches and the potential benefits of integrating Siddha medicine, a traditional Indian system, into cancer care. While conventional treatments like surgery, chemotherapy, and radiotherapy are effective, they often come with significant side effects. Siddha medicine offers a holistic perspective, focusing on restoring balance and addressing individual constitution. One notable Siddha remedy, Chithiramoola Kuligai (CMK), stands out for its historical efficacy in treating various ailments, including cervical cancer. This herbo-metallic compound, composed of Plumbago zeylanica, Tachyspermum ammi, Mercurous chloride, and Palm jaggery, demonstrates potential anti-cancer properties while mitigating treatment side effects. The paper underscores the importance of patient-centered care by highlighting the meticulous selection of raw drugs in formulating CMK based on Siddha basic principles to treat cervical cancer, thus integrating diverse therapeutic modalities to meet the complex needs of patients while emphasizing the promise of Siddha medicine in enhancing treatment outcomes and improving overall well-being.

Abstract 581 | PDF Downloads 167

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.
2. Guida F, Kidman R, Ferlay J, et al. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022; 28(12): 2563-2572. doi:10.1038/s41591-022-02109-2.
3. Preetha A, Ajaikumar BK, Chitra S, Kuzhuvelil BH, Sheeja TT, Oiki SL, Bokyung S, Bharat BA. Cancer is a Preventable Disease that Requires Major Lifestyle Changes Pharm Res. 2008;25(9):2097–11.
4. InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Overview: Cervical cancer. [Updated 2021 Sep 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279259/
5. Sankaranarayanan R, Swaminathan R, Lucas E. Cancer Survival in Africa, Asia, Caribbean and Central America: Survcan. Lyon: IARC Scientific Publication International Agency for Research on Cancer; 2010.
6. Rajarao C., Singh R.P. Improved normalized graph cut with generalized data for enhanced segmentation in cervical cancer detection. Evol. Intell. 2019;13:3–8. doi: 10.1007/s12065-019-00226-5.
7. Lin W.F., Zhong M.F., Zhou Q.H., Zhang Y.R., Wang H., Zhao Z.H., Cheng B.B., Ling C.Q. Efficacy of complementary and integrative medicine on health-related quality of life in cancer patients: A systematic review and meta-analysis. Cancer Manag. Res. 2019;11:6663–6680. doi: 10.2147/CMAR.S195935.
8. Veeramamunivar vaagada thirattu part I. Thamarai Noolagam, Chennai; 1994. P49.
9. K. S. Murugesa Mudhaliyar, Gunapadam Mooligai Part -I, 3rd edition(2018), Directorate of Indian medicine and Homeopathy, Chennai. P.385.
10. M. Vadivelu Mudhalyar, Veeramamunivar Nasa Kaandam, Re-Edition (1980), Tamil writers Forum of Puducherry, Puducherry.P.22-23.
11. Abbas Z, Rehman S. An overview of cancer treatment modalities. Neoplasm. 2018 Sep 19;1:139-57.
12. Charmsaz S, Collins DM, Perry AS, Prencipe M. Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference. Cancers (Basel). 2019 Aug 7;11(8):1125. doi: 10.3390/cancers11081125.
13. Long III HJ, Laack NN, Gostout BS. Prevention, diagnosis, and treatment of cervical cancer. InMayo Clinic Proceedings 2007 Dec 1 (Vol. 82, No. 12, pp. 1566-1574).
14. Kesic V. Management of cervical cancer. European Journal of Surgical Oncology (EJSO). 2006 Oct 1;32(8):832-7.
15. Burmeister CA, Khan SF, Schäfer G, Mbatani N, Adams T, Moodley J, Prince S. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Research. 2022 Jun 1;13:200238.
16. Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2017 Jul 1;28:iv72-83.
17. Gadducci A, Tana R, Cosio S, Cionini L. Treatment Options in Recurrent Cervical Cancer (Review). Oncology Letters. 2010 Jan;1(1):3–11. Doi:10.3892/Ol_00000001.
18. Dhruva A, Hecht FM, Miaskowski C, et al. Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study. J Altern Complement Med. 2014;20(5):364-370. doi:10.1089/acm.2013.0259.
19. Byadgi PS. Critical appraisal of DoshavahaSrotas. Ayu 2012;33(3):337e42 ;
20. Tripathi JS, Singh RH. Possible correlates of free Radicals and free radical mediated Disorders in ayurveda with special reference to BhutagniVyapara and Ama at molecular level. Ancient Sci Life 1999;19(1e2):17e20.
21. Chatterjee B, Pancholi J. Prakriti-based medicine: a step towards personalizedmedicine. Ayu 2011;32(2):141e6.
22. Shilpa S, Venkatesha Murthy CG. Understanding personality from Ayurvedic perspective for psychological assessment: A case. Ayu. 2011 Jan;32(1):12-9. doi: 10.4103/0974-8520.85716.
23. Cashman BZ. The role of deep cauterization in the prevention of cancer of the cervix: A report of ten thousand cases. American Journal of Obstetrics and Gynecology. 1941 Feb 1;41(2):216-24;
24. Peyton FW, Peyton RR, Anderson VL, Pavnica P. The importance of cauterization to maintain a healthy cervix. Long-term study from a private gynecologic practice. Am J Obstet Gynecol. 1978 Jun 15;131(4):374-80. doi: 10.1016/0002-9378(78)90410-6.
25. Blum W, Schwaller B. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? Int J Cancer. 2013 Nov;133(9):2077-88. doi: 10.1002/ijc.28218.
26. Jain DL, Apte M, Colah R, Sarathi V, Desai S, Gokhale A, Bhandarwar A, Jain HL, Ghosh K. Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience. Indian Pediatr. 2013 Oct;50(10):929-33. doi: 10.1007/s13312-013-0264-0.
27. Matsumoto S, Ikeda M, Nishikawa T. Effects of sodium and potassium channel blockers on hyperinflation-induced slowly adapting pulmonary stretch receptor stimulation in the rat. Life Sci. 2000 Sep 22;67(18):2167-75. doi: 10.1016/s0024-3205(00)00813-4.
28. Bowers DC, Adhikari S, El-Khashab YM, Gargan L, Oeffinger KC. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors. Pediatr Blood Cancer. 2009 Dec 15;53(7):1295-301. doi: 10.1002/pbc.22240.
29. Goracci C, Rengo C, Eusepi L, Juloski J, Vichi A, Ferrari M. Influence of selective enamel etching on the bonding effectiveness of a new "all-in-one" adhesive. Am J Dent. 2013 Apr;26(2):99-104.
30. (Mehmet Emin Kalender, Gazi Comez, Alper Sevinc, Ahmet Dirier, CelalettinCamci, Leech Therapy for Symptomatic Relief of Cancer Pain, Pain Medicine, Volume 11, Issue 3, March 2010, Pages 443–445, https://doi.org/10.1111/j.1526-4637.2010.00800.x.
31. Shakouri A, Wollina U. Time to Change Theory; Medical Leech from a Molecular Medicine Perspective Leech Salivary Proteins Playing a Potential Role in Medicine. Adv Pharm Bull. 2021;11(2):261-266. doi:10.34172/apb.2021.038.
32. Akiyoshi Takahashi, Chapter 9 - Opioid peptide family, Editor(s): Hironori Ando, Kazuyoshi Ukena, Shinji Nagata, Handbook of Hormones (Second Edition), Academic Press, 2021, second edition, Pages 87-89, ISBN 9780128206492,https://doi.org/10.1016/B978-0-12-820649-2.00022-X.
33. Murugesa Mudhaliyar K S.Siddha Materia Medica – Medicinal Plants Division, 2nd Re Edition. Reprint 2008; p.383, 175, 654, 656.
34. M.Sowrirajan, Patharthagunapadam, Thanjavur Saraswathy mahal, third edition, 2006, p.no 212, 406, 439;
35. I.Ponnaiyapillai. Vaithiya vilakkam ennum Amirthasaakaram pathartha soodamaniyum vaithiya thelivum, Maagana suthesa maruthuva thinai kazhlam, Sugathara amaichu, vadakku kilakku maaganam, first edition, 2000, p.no: 69.
36. R.Thiyagarajan, Gunapadam Thathu jeeva vaguppu, Department of Indian Medicine and Homeopathy, Chennai 106, eighth edition, 2013, p.no: 282.
37. O’Brien, Kylie, Karin Ried, Taufiq Binjemain, and Avni Sali. 2022. "Integrative Approaches to the Treatment of Cancer" Cancers 14(23): 5933. https://doi.org/10.3390/cancers14235933.
38. Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: an overview of pathophysiology and management. InSeminars in oncology nursing 2019 Apr 1 (Vol. 35, No. 2, pp. 166-174). WB Saunders.
39. Frazzoni L, La Marca M, Guido A, Morganti AG, Bazzoli F, Fuccio L: Pelvic radiation disease: updates on treatment options. World J Clin Oncol. 2015, 6:272-80. 10.5306/wjco.v6.i6.272.
40. Morris KA, Haboubi NY: Pelvic radiation therapy: between delight and disaster . World J Gastrointest Surg. 2015, 7:279-88. 10.4240/wjgs.v7.i11.279;
41. Klopp AH, Yeung AR, Deshmukh S, et al.: Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018, 36:2538-44. 10.1200/JCO.2017.77.4273